We tested the effect of iron deprivation on cell death induction in human Raji cells pre-adapted to differing availability of extracellular iron. Iron deprivation was achieved by incubation in a defined iron-free medium. Original Raji cells have previously been adapted to long-term culture in a defined medium with 5 microg/ml of iron-saturated human transferrin as a source of iron. Raji/lowFe cells were derived from original Raji cells by subsequent adaptation to culture in the medium with 50 microm ferric citrate as a source of iron. Raji/lowFe-re cells were derived from Raji/lowFe cells by re-adaptation to the transferrin-containing (5 microg/ml) medium. Iron deprivation induced cell death in both Raji cells and Raji/lowFe-re cells; that is, cells pre-adapted to a near optimum source of extracellular iron (5 microg/ml of transferrin). However, Raji/lowFe cells preadapted to a limited source of extracellular iron (50 microm ferric citrate) became resistant to the induction of cell death by iron deprivation. We demonstrated that cell death induction by iron deprivation in Raji cells correlates with the activation of executioner caspase-3 and the cleavage of caspase-3 substrate, poly-ADP ribose polymerase. Two other executioner caspases, caspase-7 and caspase-6, were not activated. Taken together, we suggest that in human Raji cells, iron deprivation induces apoptotic cell death related to caspase-3 activation. However, the sensitivity of the cells to death induction by iron deprivation can be reversibly changed by extracellular iron availability. The cells pre-adapted to a limited source of extracellular iron became resistant.

Department of Cell Signalling and Apoptosis Institute of Molecular Genetics Academy of Sciences of the Czech Republic Prague Czech Republic

Zobrazit více v PubMed

Chen TR (1977) In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp. Cell Res. 104, 255–262. PubMed

Donfrancesco A, Deb G, De Sio L, Cozza R, Castellano A (1996) Role of deferoxamine in tumor therapy. Acta Haematol. 95, 66–69. PubMed

Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68, 383–424. PubMed

Fink SL, Cookson BT (2005) Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 73, 1907–1916. PubMed PMC

Fukuchi K, Tomoyasu S, Tsuruoka N, Gomi K (1994) Iron deprivation‐induced apoptosis in HL‐60 cells. FEBS Lett. 350, 139–142. PubMed

Fukuda A, Osawa T, Oda H, Tanaka T, Toyokuni S, Uchida K (1996) Oxidative stress response in iron‐induced acute nephrotoxicity: enhanced expression of heat shock protein 90. Biochem. Biophys. Res. Commun. 219, 76–81. PubMed

Galea‐Louri J, Richardson AJ, Latchman DS, Katz. DR (1996) Increased heat shock protein 90 (hsp90) expression leads to increased apoptosis in the monoblastoid cell line U937 following induction with TNF‐alpha and cycloheximide: a possible role in immunopathology. J. Immunol. 157, 4109–4118. PubMed

Ghorbrial IM, Wiltzig TE, Adjei AA (2005) Targeting apoptosis pathway in cancer therapy. CA Cancer J. Clin. 55, 178–194. PubMed

Hahn MA, Mayne GC (2004) Phorbol ester‐induced cell death in PC‐12 cells overexpressing Bcl‐2 is dependent on the time at which cells are treated. Cell Biol. Int. 28, 345–359. PubMed

Haq RU, Wereley JP, Chitambar CR (1995) Induction of apoptosis by iron deprivation in human leukemic CCRF‐CEM cells. Exp. Hematol. 23, 428–432. PubMed

Hileti D, Panayiotidis P, Hoffbrand AV (1995) Iron chelators induce apoptosis in proliferating cells. Br. J. Haematol. 89, 181–187. PubMed

Ido Y, Muto N, Inada A, Kohroki J, Mano M, Odani T, Itoh N, Yamamoto K, Tanaka K (1999) Induction of apoptosis by hinokitiol, a potent iron chelator, in teratocarcinoma F9 cells is mediated through the activation of caspase‐3. Cell Prolif. 32, 63–73. PubMed PMC

Jaattela M, Tschopp M (2003) Caspase‐independent cell death in T lymphocytes. Nat. Immunol. 4, 416–423. PubMed

Jacobson MD, Weil M, Raff MC (1997) Programmed cell death in animal development. Cell 88, 347–354. PubMed

Kemp JD, Thorson JA, Stewart BC, Naumann PW (1992) Inhibition of hematopoietic tumor growth by combined treatment with deferoxamine and an IgG monoclonal antibody against the transferrin receptor: evidence for a threshold model of iron deprivation toxicity. Cancer Res. 52, 4144–4148. PubMed

Kim R. (2005) Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 103, 1551–1560. PubMed

Koc M, Nadova Z, Truksa J, Ehrlichova M, Kovar J (2005) Iron deprivation induces apoptosis via mitochondrial changes related to Bax translocation. Apoptosis 10, 381–393. PubMed

Kovar J (1988) Growth‐stimulating effect of ferric citrate on hybridoma cells: characterization and relation to transferrin function. Hybridoma 7, 255–263. PubMed

Kovar J, Franek F (1989) Growth‐stimulating effect of transferrin on a hybridoma cell line: relation to transferrin iron‐transporting function. Exp. Cell Res. 182, 358–369. PubMed

Kovar J, Seligman P, Gelfand EW (1994) Lymphocyte lines under iron‐depriving conditions: transferrin receptor expression related to various growth responses. Immunol. Lett. 42, 123–127. PubMed

Kovar J, Naumann PW, Stewart BC, Kemp JD (1995) Differing sensitivity of non‐hematopoietic human tumors to synergistic anti‐transferrin receptor monoclonal antibodies and deferoxamine in vitro . Pathobiology 63, 65–70. PubMed

Kovar J, Stunz. LL, Stewart BC, Kriegerbeckova K, Ashman RF, Kemp JD (1997a) Direct evidence that iron deprivation induces apoptosis in murine lymphoma 38C13. Pathobiology 65, 61–68. PubMed

Kovar J, Kuhn LC, Richardson V, Seiser C, Kriegerbeckova K, Musilkova J (1997b) The inability of cells to grow in low iron correlates with increasing activity of their iron regulatory protein (IRP). In Vitro Cell Dev. Biol. Anim. 33, 633–639. PubMed

Kovar J, Valenta T, Stybrova H (2001) Differing sensitivity of tumor cells to apoptosis induced by iron deprivation in vitro . In Vitro Cell Dev. Biol. Anim. 37, 450–458. PubMed

Le NT, Richardson DR (2002) The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim. Biophys. Acta 1603, 31–46. PubMed

Lill R, Diekert K, Kaut A, Lange H, Pelzer W, Prohl C, Kispal G (1999) The essential role of mitochondria in the biogenesis of cellular iron‐sulfur proteins. Biol. Chem. 380, 1157–1166. PubMed

Nardai G, Sass B, Eber J, Orosz. G, Csermely P (2000) Reactive cysteines of the 90‐kDa heat shock protein, Hsp90. Arch. Biophys. 384, 59–67. PubMed

Raff M (1998) Cell suicide for beginners. Nature 396, 119–122. PubMed

Rakba N, Loyer P, Gilot D, Delcros JG, Glaise D, Baret P, Pierre JL, Brissot P, Lescoat G (2000) Antiproliferative and apoptotic effects of O‐Trensox, a new synthetic iron chelator, on differentiated human hepatoma cell lines. Carcinogenesis 21, 943–951. PubMed

Seligman PA, Crawford ED (1991) Treatment of advanced transitional cell carcinoma of the bladder with continuous‐infusion gallium nitrate. J. Natl. Cancer Inst. 83, 1582–1584. PubMed

Shterman N, Kupfer B, Moroz C (1991) Comparison of transferrin receptors, iron content and isoferritin profile in normal and malignant human breast cell lines. Pathobiology 59, 19–25. PubMed

Simonart T, Boelaert JR, Mosselmans R. (2002) Antiproliferative and apoptotic effect of iron chelators on human cervical carcinoma cells. Gynecol. Oncol. 85, 95–102. PubMed

Simonart T, Degraef C, Andrei G, Mosselmans R, Hermans P, Van Vooren JP, Noel JC, Boelaert JR, Snoeck R, Heenen M (2000) Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors. J. Invest. Dermatol. 115, 893–900. PubMed

Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76–85. PubMed

Taetle R, Honeysett JM, Bergeron R. (1989) Combination iron depletion therapy. J. Natl. Cancer Inst. 81, 1229–1235. PubMed

Thelander L, Graslund A, Thelander M (1983) Continual presence of oxygen and iron required for mammalian ribonucleotide reduction: possible regulation mechanism. Biochem. Biophys. Res. Commun. 110, 859–865. PubMed

Truksa J, Kovar J, Valenta T, Ehrlichova M, Polak J, Naumann PW (2003) Iron deprivation induces apoptosis independently of p53 in human and murine tumour cells. Cell Prolif. 36, 199–213. PubMed PMC

White S, Taetle R, Seligman PA, Rutherford M, Trowbridge IS (1990) Combinations of anti‐transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. Cancer Res. 50, 6295–6301. PubMed

Yao K, Gietema JA, Shida S, Selvakumaran M, Fonrose X, Haas NB, Testa J, O'Dwyer PJ (2005) In vitro hypoxia‐conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo . Br. J. Cancer 93, 1356–1363. PubMed PMC